Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-02

AUTHORS

Noam Shohat, Andrew Fleischman, Majd Tarabichi, Timothy L Tan, Javad Parvizi

ABSTRACT

BACKGROUND: Although morbid obesity is considered a modifiable risk factor for periprosthetic joint infection (PJI), there is no consensus regarding an appropriate threshold for body mass index (BMI) above which a high risk for infection may outweigh the benefits of surgery. QUESTIONS/PURPOSES: (1) Is there a BMI cutoff threshold that is associated with increased risk for PJI? (2) Is the risk of PJI increased in higher obesity classes? METHODS: A retrospective study was conducted of all primary THAs and TKAs performed at one institution between 2006 and 2015. Overall 19,226 patients were eligible to be included in the study; 1053 patients were excluded as a result of incomplete data, resulting in a final cohort of 18,173 patients (8757 TKAs and 9416 THAs). PJI was defined using the International Consensus Meeting criteria. To ensure accurate followup, and because there is evidence to support the association between obesity and early infection, we identified PJI within 90 days of the index surgery. This relationship was examined separately for BMI as a continuous variable and for each BMI category as defined by the Centers for Disease Control and Prevention (underweight ≤ 18.49 kg/m; normal 18.5-24.9 kg/m; overweight 25-29.9 kg/m; obese class I 30-34.9 kg/m; obese class II 35-39.9 kg/m; obese class III ≥ 40 kg/m). Analyses were performed with logistic regression, accounting for both patient and surgical risk factors. A BMI threshold was evaluated with a receiver operating characteristic (ROC) curve and the Youden index. RESULTS: The area under the ROC curve for BMI and risk of PJI within 90 days was only 0.58 (confidence interval [CI], 0.52-0.63) suggesting such a cutoff was not much better than random chance. Among the BMI classes, patients with class III obesity (≥ 40 kg/m) were the only ones showing a higher risk for PJI within 90 days (odds ratio [OR], 3.09 [1.46-6.54]; p = 0.003). The risk of developing PJI was not greater for overweight (OR, 0.72; 95% CI, 0.38-1.4), class I obese (OR, 1.06; 95% CI, 0.57-2.0), or class II obese (OR, 1.08; 95% CI, 0.52-2.2) patients. Underweight patients also demonstrated no increased risk for PJI (OR, 1.80; 95% CI, 0.23-13.9). CONCLUSIONS: The risk for infection increases gradually throughout the full range of BMI, but no threshold exists. Weight reduction before surgery may mitigate risk for infection for all patients with a BMI above normal. Of note, patients with a BMI > 40 kg/m carried a threefold higher risk for PJI and for these patients, the risks of surgery must be carefully weighed against its benefits. LEVEL OF EVIDENCE: Level III, therapeutic study. More... »

PAGES

1964-1969

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11999.0000000000000141

DOI

http://dx.doi.org/10.1007/s11999.0000000000000141

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105228166

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30794240


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Thomas Jefferson University", 
          "id": "https://www.grid.ac/institutes/grid.265008.9", 
          "name": [
            "N. Shohat, A. Fleischman, M. Tarabichi, T. L. Tan, J. Parvizi, The Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA N. Shohat, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shohat", 
        "givenName": "Noam", 
        "id": "sg:person.014140572163.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014140572163.72"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Fleischman", 
        "givenName": "Andrew", 
        "id": "sg:person.016337502053.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016337502053.03"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Tarabichi", 
        "givenName": "Majd", 
        "id": "sg:person.012217741247.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012217741247.90"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Tan", 
        "givenName": "Timothy L", 
        "id": "sg:person.01103301641.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103301641.41"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Parvizi", 
        "givenName": "Javad", 
        "id": "sg:person.01357752371.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357752371.70"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-02", 
    "datePublishedReg": "2018-02-01", 
    "description": "BACKGROUND: Although morbid obesity is considered a modifiable risk factor for periprosthetic joint infection (PJI), there is no consensus regarding an appropriate threshold for body mass index (BMI) above which a high risk for infection may outweigh the benefits of surgery.\nQUESTIONS/PURPOSES: (1) Is there a BMI cutoff threshold that is associated with increased risk for PJI? (2) Is the risk of PJI increased in higher obesity classes?\nMETHODS: A retrospective study was conducted of all primary THAs and TKAs performed at one institution between 2006 and 2015. Overall 19,226 patients were eligible to be included in the study; 1053 patients were excluded as a result of incomplete data, resulting in a final cohort of 18,173 patients (8757 TKAs and 9416 THAs). PJI was defined using the International Consensus Meeting criteria. To ensure accurate followup, and because there is evidence to support the association between obesity and early infection, we identified PJI within 90 days of the index surgery. This relationship was examined separately for BMI as a continuous variable and for each BMI category as defined by the Centers for Disease Control and Prevention (underweight \u2264 18.49 kg/m; normal 18.5-24.9 kg/m; overweight 25-29.9 kg/m; obese class I 30-34.9 kg/m; obese class II 35-39.9 kg/m; obese class III \u2265 40 kg/m). Analyses were performed with logistic regression, accounting for both patient and surgical risk factors. A BMI threshold was evaluated with a receiver operating characteristic (ROC) curve and the Youden index.\nRESULTS: The area under the ROC curve for BMI and risk of PJI within 90 days was only 0.58 (confidence interval [CI], 0.52-0.63) suggesting such a cutoff was not much better than random chance. Among the BMI classes, patients with class III obesity (\u2265 40 kg/m) were the only ones showing a higher risk for PJI within 90 days (odds ratio [OR], 3.09 [1.46-6.54]; p = 0.003). The risk of developing PJI was not greater for overweight (OR, 0.72; 95% CI, 0.38-1.4), class I obese (OR, 1.06; 95% CI, 0.57-2.0), or class II obese (OR, 1.08; 95% CI, 0.52-2.2) patients. Underweight patients also demonstrated no increased risk for PJI (OR, 1.80; 95% CI, 0.23-13.9).\nCONCLUSIONS: The risk for infection increases gradually throughout the full range of BMI, but no threshold exists. Weight reduction before surgery may mitigate risk for infection for all patients with a BMI above normal. Of note, patients with a BMI > 40 kg/m carried a threefold higher risk for PJI and for these patients, the risks of surgery must be carefully weighed against its benefits.\nLEVEL OF EVIDENCE: Level III, therapeutic study.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11999.0000000000000141", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1007212", 
        "issn": [
          "0009-921X", 
          "1528-1132"
        ], 
        "name": "Clinical Orthopaedics and Related Research\u00ae", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "476"
      }
    ], 
    "name": "Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index Threshold?", 
    "pagination": "1964-1969", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30794240"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0075674"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11999.0000000000000141"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105228166"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11999.0000000000000141", 
      "https://app.dimensions.ai/details/publication/pub.1105228166"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99836_00000004.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://Insights.ovid.com/crossref?an=00003086-900000000-98630"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11999.0000000000000141'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11999.0000000000000141'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11999.0000000000000141'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11999.0000000000000141'


 

This table displays all metadata directly associated to this object as RDF triples.

89 TRIPLES      20 PREDICATES      28 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11999.0000000000000141 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N39f9db8a3fba4cf1ae076527ba117a63
4 schema:datePublished 2018-02
5 schema:datePublishedReg 2018-02-01
6 schema:description BACKGROUND: Although morbid obesity is considered a modifiable risk factor for periprosthetic joint infection (PJI), there is no consensus regarding an appropriate threshold for body mass index (BMI) above which a high risk for infection may outweigh the benefits of surgery. QUESTIONS/PURPOSES: (1) Is there a BMI cutoff threshold that is associated with increased risk for PJI? (2) Is the risk of PJI increased in higher obesity classes? METHODS: A retrospective study was conducted of all primary THAs and TKAs performed at one institution between 2006 and 2015. Overall 19,226 patients were eligible to be included in the study; 1053 patients were excluded as a result of incomplete data, resulting in a final cohort of 18,173 patients (8757 TKAs and 9416 THAs). PJI was defined using the International Consensus Meeting criteria. To ensure accurate followup, and because there is evidence to support the association between obesity and early infection, we identified PJI within 90 days of the index surgery. This relationship was examined separately for BMI as a continuous variable and for each BMI category as defined by the Centers for Disease Control and Prevention (underweight ≤ 18.49 kg/m; normal 18.5-24.9 kg/m; overweight 25-29.9 kg/m; obese class I 30-34.9 kg/m; obese class II 35-39.9 kg/m; obese class III ≥ 40 kg/m). Analyses were performed with logistic regression, accounting for both patient and surgical risk factors. A BMI threshold was evaluated with a receiver operating characteristic (ROC) curve and the Youden index. RESULTS: The area under the ROC curve for BMI and risk of PJI within 90 days was only 0.58 (confidence interval [CI], 0.52-0.63) suggesting such a cutoff was not much better than random chance. Among the BMI classes, patients with class III obesity (≥ 40 kg/m) were the only ones showing a higher risk for PJI within 90 days (odds ratio [OR], 3.09 [1.46-6.54]; p = 0.003). The risk of developing PJI was not greater for overweight (OR, 0.72; 95% CI, 0.38-1.4), class I obese (OR, 1.06; 95% CI, 0.57-2.0), or class II obese (OR, 1.08; 95% CI, 0.52-2.2) patients. Underweight patients also demonstrated no increased risk for PJI (OR, 1.80; 95% CI, 0.23-13.9). CONCLUSIONS: The risk for infection increases gradually throughout the full range of BMI, but no threshold exists. Weight reduction before surgery may mitigate risk for infection for all patients with a BMI above normal. Of note, patients with a BMI > 40 kg/m carried a threefold higher risk for PJI and for these patients, the risks of surgery must be carefully weighed against its benefits. LEVEL OF EVIDENCE: Level III, therapeutic study.
7 schema:genre research_article
8 schema:inLanguage en
9 schema:isAccessibleForFree false
10 schema:isPartOf N078cf87c898f4194b446f0a24a3b7422
11 N7d0565d3487b49f09c3f445bd8cc4513
12 sg:journal.1007212
13 schema:name Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index Threshold?
14 schema:pagination 1964-1969
15 schema:productId N269429fd686541c084b681015b51bbdc
16 N63561b27da934891b7bc42ceb68247ad
17 N7c9aa7984f944cdbb8a0993a89dcd97c
18 Nc5ac200680c94ec7b4864d3fedcc1c1e
19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105228166
20 https://doi.org/10.1007/s11999.0000000000000141
21 schema:sdDatePublished 2019-04-11T09:40
22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
23 schema:sdPublisher Nf48fe5dd83cd4ff08555f61dab7bf685
24 schema:url http://Insights.ovid.com/crossref?an=00003086-900000000-98630
25 sgo:license sg:explorer/license/
26 sgo:sdDataset articles
27 rdf:type schema:ScholarlyArticle
28 N078cf87c898f4194b446f0a24a3b7422 schema:volumeNumber 476
29 rdf:type schema:PublicationVolume
30 N269429fd686541c084b681015b51bbdc schema:name pubmed_id
31 schema:value 30794240
32 rdf:type schema:PropertyValue
33 N39f9db8a3fba4cf1ae076527ba117a63 rdf:first sg:person.014140572163.72
34 rdf:rest N80251b6be16142be8d17e13e947dafbf
35 N63561b27da934891b7bc42ceb68247ad schema:name dimensions_id
36 schema:value pub.1105228166
37 rdf:type schema:PropertyValue
38 N7469e6ab8e654a84b71d253512c49047 rdf:first sg:person.01357752371.70
39 rdf:rest rdf:nil
40 N7c9aa7984f944cdbb8a0993a89dcd97c schema:name nlm_unique_id
41 schema:value 0075674
42 rdf:type schema:PropertyValue
43 N7d0565d3487b49f09c3f445bd8cc4513 schema:issueNumber 10
44 rdf:type schema:PublicationIssue
45 N80251b6be16142be8d17e13e947dafbf rdf:first sg:person.016337502053.03
46 rdf:rest N85fd0571592f462595d6afea5da8443e
47 N85fd0571592f462595d6afea5da8443e rdf:first sg:person.012217741247.90
48 rdf:rest Nb251b573d8b94ecf94d57d849b87df9d
49 Nb251b573d8b94ecf94d57d849b87df9d rdf:first sg:person.01103301641.41
50 rdf:rest N7469e6ab8e654a84b71d253512c49047
51 Nc5ac200680c94ec7b4864d3fedcc1c1e schema:name doi
52 schema:value 10.1007/s11999.0000000000000141
53 rdf:type schema:PropertyValue
54 Nf48fe5dd83cd4ff08555f61dab7bf685 schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
57 schema:name Medical and Health Sciences
58 rdf:type schema:DefinedTerm
59 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
60 schema:name Clinical Sciences
61 rdf:type schema:DefinedTerm
62 sg:journal.1007212 schema:issn 0009-921X
63 1528-1132
64 schema:name Clinical Orthopaedics and Related Research®
65 rdf:type schema:Periodical
66 sg:person.01103301641.41 schema:familyName Tan
67 schema:givenName Timothy L
68 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103301641.41
69 rdf:type schema:Person
70 sg:person.012217741247.90 schema:familyName Tarabichi
71 schema:givenName Majd
72 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012217741247.90
73 rdf:type schema:Person
74 sg:person.01357752371.70 schema:familyName Parvizi
75 schema:givenName Javad
76 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357752371.70
77 rdf:type schema:Person
78 sg:person.014140572163.72 schema:affiliation https://www.grid.ac/institutes/grid.265008.9
79 schema:familyName Shohat
80 schema:givenName Noam
81 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014140572163.72
82 rdf:type schema:Person
83 sg:person.016337502053.03 schema:familyName Fleischman
84 schema:givenName Andrew
85 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016337502053.03
86 rdf:type schema:Person
87 https://www.grid.ac/institutes/grid.265008.9 schema:alternateName Thomas Jefferson University
88 schema:name N. Shohat, A. Fleischman, M. Tarabichi, T. L. Tan, J. Parvizi, The Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA N. Shohat, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
89 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...